Valuation : GENFIT

Market Cap 679M 790M 639M 583M 1.09B 74.71B 1.09B 7.58B 2.93B 38.26B 2.97B 2.9B 122B P/E 2026 *
35x
P/E 2027 * 90.2x
Enterprise Value 628M 730M 591M 539M 1.01B 69.08B 1.01B 7.01B 2.71B 35.38B 2.74B 2.68B 113B EV / Sales 2026 *
6.27x
EV / Sales 2027 * 4.94x
Free-Float
86.89%
Yield 2026 *
-
Yield 2027 * -
1 day-1.45%
1 week-3.96%
Current month-3.96%
1 month-0.59%
3 months+54.85%
6 months+59.39%
Current year+157.93%
1 week 13.36
Extreme 13.36
14.84
1 month 12.74
Extreme 12.74
14.98
Current year 5.05
Extreme 5.05
15.48
1 year 3.05
Extreme 3.048
15.48
3 years 2.62
Extreme 2.62
15.48
5 years 2.62
Extreme 2.62
15.48
10 years 2.62
Extreme 2.62
35.65
Manager TitleAgeSince
Chief Executive Officer 58 2019-09-15
Director of Finance/CFO 52 2021-04-21
Chief Tech/Sci/R&D Officer - 2025-11-26
Director TitleAgeSince
Chairman 70 2017-06-15
Director/Board Member 54 1999-09-14
Director/Board Member 58 2017-06-15
Date Insider Type Main position Quantity % Market Cap. Importance
3/5/26 Exercice

Chief Operating Officer

11,250 0.0225%
3/5/26 Exercice

Chief Operating Officer

7,083 0.0142%
3/5/26 Sell

Chief Operating Officer

7,083 0.0142%
Change 5-day change 1-year change 3-year change Capi.($)
-1.45%-3.96%+294.54%+290.23% 801M
-1.16%-3.97%-2.91%+13.00% 48.93B
-0.40%+2.16%+418.57%+554.47% 45.01B
-1.42%+2.52%+42.67%+22.27% 44.07B
-1.22%-0.37%+4.82%+84.42% 40.73B
-0.96%-2.31%+15.75%+45.41% 33.52B
-0.21%+2.86% - - 17.77B
-0.35%-0.45%+21.42%+117.63% 16.5B
-1.54%-1.30%+12.16%+31.14% 14.67B
-1.65%+0.09%+75.93%+41.15% 13.77B
Average -1.04%-0.14%+98.10%+133.30% 27.58B
Weighted average by Cap. -1.00%-0.06%+89.60%+134.62%

Financials

2026 *2027 *
Net sales 100M 117M 94.24M 86.03M 161M 11.02B 161M 1.12B 432M 5.64B 438M 428M 17.97B 124M 144M 117M 107M 199M 13.64B 200M 1.38B 535M 6.99B 542M 530M 22.25B
Net income 22.88M 26.6M 21.52M 19.64M 36.74M 2.52B 36.85M 255M 98.62M 1.29B 99.9M 97.72M 4.1B 6.8M 7.91M 6.4M 5.84M 10.92M 748M 10.95M 75.83M 29.31M 383M 29.69M 29.04M 1.22B
Net Debt -51.12M -59.44M -48.08M -43.89M -82.08M -5.62B -82.35M -570M -220M -2.88B -223M -218M -9.17B -66.17M -76.95M -62.24M -56.81M -106M -7.28B -107M -738M -285M -3.73B -289M -283M -11.87B
Logo GENFIT
GENFIT is a biopharmaceutical company in late-stage development focused on the discovery and development of innovative therapeutic and diagnostic solutions in the field of liver diseases, particularly of metabolic origin, where unmet medical needs are considerable, in particular due to a lack of approved treatments. GENFIT is a leading innovator in the field of nuclear receptor-based drug discovery with a rich history and a solid scientific heritage spanning nearly two decades. The company has offices in Lille, Paris, Zurich and Cambridge, MA (USA).
Employees
161
Date Price Change Volume
26-09-07 €13.58 -1.45% 160,877
26-09-04 €13.78 -0.58% 127,027
26-09-03 €13.86 -2.67% 225,236
26-09-02 €14.24 +0.85% 195,719
26-09-01 €14.12 -0.14% 146,344
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
13.58EUR
Average target price
15.90EUR
Spread / Average Target
+17.08%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GNFT Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!